Ost-müük Anixa Biosciences, Inc. - ANIX CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Kauplemistingimused
| Hinnavahe | 0.23 | ||||||||
|
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024874% | ||||||||
|
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.002651% | ||||||||
| Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
| Min kauplemise kogus | 1 | ||||||||
| Valuuta | USD | ||||||||
| Tagatis | 20% | ||||||||
| Aktsiabörs | United States of America | ||||||||
| Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Võtmestatistika
| Eelmine sulgemine* | 2.97 |
| Avatud* | 2.94 |
| Aastane muutus* | -1.67% |
| Päeva ulatus* | 2.9 - 3.04 |
| 52 nädala ulatus | 2.50-6.25 |
| Keskmine maht (10 päeva) | 61.46K |
| Keskmine maht (3 kuud) | 1.10M |
| Turukapitalisatsioon | 143.80M |
| P/E suhtarv | -100.00K |
| Ringluses olevad aktsiad | 30.92M |
| Tulu | N/A |
| EPS | -0.40 |
| Dividendid (% kasumist) | N/A |
| Beeta | 0.96 |
| Järgmine tuluaruande kuupäev | N/A |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | 2.99 | 0.05 | 1.70% | 2.94 | 3.08 | 2.90 |
| Jun 28, 2022 | 2.97 | -0.04 | -1.33% | 3.01 | 3.14 | 2.95 |
| Jun 27, 2022 | 3.16 | 0.15 | 4.98% | 3.01 | 3.19 | 3.01 |
| Jun 24, 2022 | 3.04 | 0.07 | 2.36% | 2.97 | 3.12 | 2.97 |
| Jun 23, 2022 | 3.13 | 0.11 | 3.64% | 3.02 | 3.19 | 3.02 |
| Jun 22, 2022 | 3.18 | 0.21 | 7.07% | 2.97 | 3.18 | 2.97 |
| Jun 21, 2022 | 3.08 | 0.06 | 1.99% | 3.02 | 3.19 | 3.02 |
| Jun 17, 2022 | 3.00 | -0.16 | -5.06% | 3.16 | 3.16 | 2.96 |
| Jun 16, 2022 | 3.10 | 0.15 | 5.08% | 2.95 | 3.18 | 2.90 |
| Jun 15, 2022 | 3.08 | 0.29 | 10.39% | 2.79 | 3.15 | 2.79 |
| Jun 14, 2022 | 2.88 | -0.18 | -5.88% | 3.06 | 3.09 | 2.82 |
| Jun 13, 2022 | 3.07 | -0.18 | -5.54% | 3.25 | 3.31 | 3.04 |
| Jun 10, 2022 | 3.33 | -0.10 | -2.92% | 3.43 | 3.48 | 3.27 |
| Jun 9, 2022 | 3.48 | 0.07 | 2.05% | 3.41 | 3.68 | 3.41 |
| Jun 8, 2022 | 3.50 | 0.23 | 7.03% | 3.27 | 3.54 | 3.27 |
| Jun 7, 2022 | 3.38 | -0.49 | -12.66% | 3.87 | 3.91 | 3.30 |
| Jun 6, 2022 | 3.92 | -0.27 | -6.44% | 4.19 | 4.44 | 3.87 |
| Jun 3, 2022 | 3.94 | 0.16 | 4.23% | 3.78 | 3.96 | 3.61 |
| Jun 2, 2022 | 3.81 | 0.01 | 0.26% | 3.80 | 3.85 | 3.74 |
| Jun 1, 2022 | 3.69 | 0.18 | 5.13% | 3.51 | 3.70 | 3.37 |
Anixa Biosciences, Inc. Events
| Kellaaeg (UTC) (UTC) | Riik | Sündmus |
|---|---|---|
| No events scheduled | ||
- Aastas
- Kvartalis
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Kogutulu | 0 | 0.5125 | 0 | 0.25 | 1.1125 |
| Tulu | 0 | 0.5125 | 0 | 0.25 | 1.1125 |
| Kogu tegevuskulu | 13.875 | 13.6482 | 9.9782 | 12.14 | 15.4016 |
| Müük/Üldine/admin kulud, kokku | 7.172 | 7.0735 | 5.597 | 5.66283 | 6.91183 |
| Uuringud ja arendus | 6.703 | 6.18969 | 4.38121 | 5.47343 | 6.81304 |
| Depreciation / Amortization | 0 | 0.41875 | 0.3253 | ||
| Ootamatud kulutused (tulu) | 0 | 0.385 | 0 | 0.585 | 1.35139 |
| Other Operating Expenses, Total | |||||
| Tulud majandustegevusest | -13.875 | -13.1357 | -9.9782 | -11.89 | -14.2891 |
| Intressitulud (kulu), muud tulud, neto | 0.104 | 0.00232 | 0.03392 | 0.07135 | 0.04597 |
| Netotulu enne makse | -13.771 | -13.1279 | -10.0924 | -11.8187 | -14.2431 |
| Netotulu pärast makse | -13.771 | -13.1279 | -10.0924 | -11.8187 | -14.2431 |
| Netotulu enne erikulusid | -13.595 | -12.9544 | -10.0184 | -11.647 | -13.996 |
| Netotulu | -13.595 | -12.9544 | -10.0184 | -11.647 | -13.996 |
| Arvestatav tulu, v a erikulud | -13.595 | -12.9544 | -10.0184 | -11.647 | -13.996 |
| Arvestatav tulu, koos erikuludega | -13.595 | -12.9544 | -10.0184 | -11.647 | -13.996 |
| Jaotamisele kuuluv netotulu | -13.595 | -12.9544 | -10.0184 | -11.647 | -13.996 |
| Keskmine jaotamisele kuuluv aktsia kohta | 30.374 | 28.5789 | 22.229 | 19.7898 | 17.6243 |
| Jaotatav EPS, v a erakorralised kulud | -0.44759 | -0.45329 | -0.45069 | -0.58854 | -0.79413 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Jaotamisele kuuluv normaal-EPS | -0.44759 | -0.44 | -0.44403 | -0.55898 | -0.71745 |
| Total Adjustments to Net Income | 0 | ||||
| Vähemuse intress | 0.176 | 0.17352 | 0.07401 | 0.1716 | 0.24706 |
| Gain (Loss) on Sale of Assets | 0 | 0.00545 | -0.14808 |
| Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | |
|---|---|---|---|---|---|
| Kogutulu | 0 | 0 | 0 | 0 | 0 |
| Tulu | 0 | 0 | 0 | 0 | 0 |
| Kogu tegevuskulu | 3.609 | 2.797 | 3.589 | 3.88 | 4.07704 |
| Müük/Üldine/admin kulud, kokku | 1.924 | 1.352 | 1.854 | 2.042 | 1.9038 |
| Uuringud ja arendus | 1.685 | 1.445 | 1.735 | 1.838 | 2.17324 |
| Ootamatud kulutused (tulu) | 0 | 0 | 0 | 0 | 0 |
| Tulud majandustegevusest | -3.609 | -2.797 | -3.589 | -3.88 | -4.07704 |
| Intressitulud (kulu), muud tulud, neto | 0.08 | 0.022 | 0.001 | 0.001 | 0.00055 |
| Netotulu enne makse | -3.529 | -2.775 | -3.588 | -3.879 | -4.07105 |
| Netotulu pärast makse | -3.529 | -2.775 | -3.588 | -3.879 | -4.07105 |
| Vähemuse intress | 0.053 | 0.029 | 0.044 | 0.05 | 0.05778 |
| Netotulu enne erikulusid | -3.476 | -2.746 | -3.544 | -3.829 | -4.01327 |
| Netotulu | -3.476 | -2.746 | -3.544 | -3.829 | -4.01327 |
| Arvestatav tulu, v a erikulud | -3.476 | -2.746 | -3.544 | -3.829 | -4.01327 |
| Arvestatav tulu, koos erikuludega | -3.476 | -2.746 | -3.544 | -3.829 | -4.01327 |
| Jaotamisele kuuluv netotulu | -3.476 | -2.746 | -3.544 | -3.829 | -4.01327 |
| Keskmine jaotamisele kuuluv aktsia kohta | 30.764 | 30.451 | 30.152 | 30.125 | 30.0451 |
| Jaotatav EPS, v a erakorralised kulud | -0.11299 | -0.09018 | -0.11754 | -0.1271 | -0.13357 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
| Jaotamisele kuuluv normaal-EPS | -0.11299 | -0.09018 | -0.11754 | -0.1271 | -0.13376 |
| Gain (Loss) on Sale of Assets | 0 | 0.00545 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 36.0034 | 9.36862 | 6.09312 | 5.53837 | 7.01394 |
| Raha ja lühiajalised investeeringud | 35.7279 | 9.05706 | 5.84163 | 5.05589 | 6.83937 |
| Raha ja ekvivalendid | 29.1283 | 6.41706 | 3.49163 | 3.05589 | 3.33937 |
| Lühiajalised investeeringud | 6.5996 | 2.64 | 2.35 | 2 | 3.5 |
| Prepaid Expenses | 0.27556 | 0.30933 | 0.18497 | 0.17549 | 0.17457 |
| Total Assets | 36.2574 | 9.45296 | 6.29369 | 6.44854 | 8.81242 |
| Property/Plant/Equipment, Total - Net | 0.25396 | 0.05434 | 0.20057 | 0.07267 | 0.0527 |
| Property/Plant/Equipment, Total - Gross | 0 | 0.29558 | 0.12647 | 0.08843 | |
| Accumulated Depreciation, Total | 0 | -0.09502 | -0.0538 | -0.03573 | |
| Intangibles, Net | 0 | 0.8375 | 1.74578 | ||
| Total Current Liabilities | 1.27053 | 1.18859 | 1.48132 | 1.26511 | 0.88949 |
| Accounts Payable | 0.1362 | 0.23237 | 0.58582 | 0.58201 | 0.48032 |
| Accrued Expenses | 1.13433 | 0.95622 | 0.8955 | 0.6831 | 0.40917 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | |||||
| Total Liabilities | 0.8201 | 0.69161 | 1.05834 | 1.01373 | 0.88949 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 0.22008 | 0 | |||
| Total Equity | 35.4373 | 8.76136 | 5.23535 | 5.43481 | 7.92292 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
| Common Stock | 0.30051 | 0.24249 | 0.20332 | 0.18909 | 0.16603 |
| Additional Paid-In Capital | 239.927 | 200.354 | 186.849 | 175.416 | 163.931 |
| Retained Earnings (Accumulated Deficit) | -204.79 | -191.836 | -181.817 | -170.17 | -156.174 |
| Total Liabilities & Shareholders’ Equity | 36.2574 | 9.45296 | 6.29369 | 6.44854 | 8.81242 |
| Total Common Shares Outstanding | 30.0509 | 24.2487 | 20.3318 | 18.9086 | 16.6028 |
| Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
| Laekumata arved, neto | 0.00223 | 0.06653 | 0.30699 | ||
| Accounts Receivable - Trade, Net | 0.00223 | 0.06653 | 0.30699 | ||
| Minority Interest | -0.67051 | -0.49698 | -0.42298 | -0.25138 | |
| Other Long Term Assets, Total | 0 | 0.03 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 32.563 | 34.994 | 36.0034 | 37.052 | 38.472 |
| Raha ja lühiajalised investeeringud | 32.231 | 34.53 | 35.7279 | 36.622 | 38.1027 |
| Raha ja ekvivalendid | 27.732 | 29.781 | 29.1283 | 27.2222 | 27.7034 |
| Lühiajalised investeeringud | 4.499 | 4.749 | 6.5996 | 9.39978 | 10.3993 |
| Prepaid Expenses | 0.332 | 0.464 | 0.27556 | 0.43001 | 0.36921 |
| Total Assets | 32.797 | 35.238 | 36.2574 | 37.0624 | 38.4975 |
| Property/Plant/Equipment, Total - Net | 0.234 | 0.244 | 0.25396 | 0.01041 | 0.02557 |
| Other Long Term Assets, Total | 0 | 0 | 0 | ||
| Total Current Liabilities | 1.189 | 1.787 | 1.27053 | 1.20802 | 1.44287 |
| Accounts Payable | 0.093 | 0.504 | 0.1362 | 0.20773 | 0.43801 |
| Accrued Expenses | 1.096 | 1.283 | 1.13433 | 1.00029 | 1.00486 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 0.626 | 1.275 | 0.8201 | 0.5953 | 0.88376 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -0.765 | -0.721 | -0.67051 | -0.61273 | -0.55911 |
| Total Equity | 32.171 | 33.963 | 35.4373 | 36.4671 | 37.6138 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.302 | 0.301 | 0.30051 | 0.2995 | 0.3145 |
| Additional Paid-In Capital | 244.032 | 242.281 | 239.927 | 236.944 | 233.742 |
| Retained Earnings (Accumulated Deficit) | -212.163 | -208.619 | -204.79 | -200.777 | -196.443 |
| Total Liabilities & Shareholders’ Equity | 32.797 | 35.238 | 36.2574 | 37.0624 | 38.4975 |
| Total Common Shares Outstanding | 30.1547 | 30.1323 | 30.0509 | 29.9499 | 31.4499 |
| Other Liabilities, Total | 0.202 | 0.209 | 0.22008 | ||
| Total Preferred Shares Outstanding | 0 |
- Aastas
- Kvartalis
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Netotulu/algväärtus | -13.1279 | -10.0924 | -11.8187 | -14.2431 | -5.00899 |
| Raha majandustegevusest | -4.93688 | -6.17567 | -4.74143 | -4.2734 | -3.79671 |
| Raha majandustegevusest | 0 | 0.03828 | 0.04756 | 0.01844 | 0.04322 |
| Amortization | 0 | 0.41875 | 0.3253 | 0.3253 | |
| Mittelikviidsed varad | 8.1125 | 4.33743 | 6.1325 | 9.55825 | 0.43553 |
| Muutused tööjõus | 0.07855 | -0.45901 | 0.47842 | 0.0677 | 0.40824 |
| Tulu investeeringutelt | -3.91768 | -0.30579 | -0.52546 | 1.4616 | -2.73519 |
| Kapitalikulutused | 0 | -0.01579 | -0.17546 | -0.0384 | -0.03019 |
| Muud rahavood investeeringutelt, kokku | -3.91768 | -0.29 | -0.35 | 1.5 | -2.705 |
| Rahavood investeeringutelt | 31.5658 | 9.4069 | 5.70262 | 2.52832 | 7.38295 |
| Rahavoogudesse investeerimine | 0.01403 | 0 | |||
| Aktsiate emiteerimine (tagasiost), neto | 31.5658 | 9.4069 | 5.68858 | 2.52832 | 10.3829 |
| Rahaline kogumuutus | 22.7112 | 2.92544 | 0.43574 | -0.28348 | 0.85105 |
| Makstud intressid | 0.00182 | 0.03989 | 0 | 0.27243 | |
| Laenu väljastamine (kustutamine), neto | 0 | -3 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -7.467 | -3.879 | -13.1279 | -9.05688 | -4.66927 |
| Cash From Operating Activities | -3.503 | -1.197 | -4.93688 | -3.89271 | -2.41195 |
| Cash From Operating Activities | 0 | 0 | 0 | ||
| Non-Cash Items | 4.12 | 2.364 | 8.1125 | 5.26318 | 2.06069 |
| Cash Interest Paid | 2 | 1 | 0.00182 | 0.00168 | 0.0014 |
| Changes in Working Capital | -0.156 | 0.318 | 0.07855 | -0.09901 | 0.19663 |
| Cash From Investing Activities | 2.1 | 1.85 | -3.91768 | -6.72434 | -7.72385 |
| Capital Expenditures | 0 | 0 | 0 | ||
| Other Investing Cash Flow Items, Total | 2.1 | 1.85 | -3.91768 | -6.72434 | -7.72385 |
| Cash From Financing Activities | 0.007 | 0 | 31.5658 | 31.4222 | 31.4222 |
| Financing Cash Flow Items | 0 | -2.54893 | -2.54893 | ||
| Issuance (Retirement) of Stock, Net | 0.007 | 0 | 31.5658 | 33.9711 | 33.9711 |
| Net Change in Cash | -1.396 | 0.653 | 22.7112 | 20.8051 | 21.2864 |
| Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.2268 | 1307142 | 7144 | 2022-12-31 | LOW |
| Titterton (Lewis H Jr) | Individual Investor | 2.5031 | 774070 | 0 | 2023-01-17 | LOW |
| UBS Financial Services, Inc. | Investment Advisor | 2.0131 | 622544 | 853 | 2022-12-31 | LOW |
| Kumar (Amit) | Individual Investor | 1.4943 | 462100 | 0 | 2023-01-17 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.9353 | 289238 | -2985 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.887 | 274289 | 3626 | 2022-12-31 | LOW |
| Long Focus Capital Management LLC | Hedge Fund | 0.5358 | 165701 | 0 | 2022-12-31 | MED |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3302 | 102100 | 0 | 2022-12-31 | LOW |
| Baskies (Arnold M) | Individual Investor | 0.3234 | 100000 | 0 | 2023-01-17 | LOW |
| Susquehanna International Group, LLP | Investment Advisor | 0.2297 | 71023 | 31115 | 2022-12-31 | MED |
| Raymond James & Associates, Inc. | Research Firm | 0.185 | 57217 | -3629 | 2022-12-31 | LOW |
| Newton Investment Management North America, LLC | Investment Advisor | 0.179 | 55350 | 0 | 2022-12-31 | MED |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1777 | 54948 | 0 | 2022-12-31 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.1582 | 48925 | -714 | 2022-12-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.1549 | 47900 | -9300 | 2022-12-31 | HIGH |
| Citadel Advisors LLC | Hedge Fund | 0.1536 | 47506 | 27896 | 2022-12-31 | HIGH |
| Gottschalk (Emily) | Individual Investor | 0.1477 | 45665 | 0 | 2023-01-17 | LOW |
| BNY Mellon Asset Management | Investment Advisor | 0.1367 | 42268 | -238 | 2022-12-31 | LOW |
| Cambridge Investment Research Advisors, Inc. | Investment Advisor | 0.1297 | 40100 | 25100 | 2022-12-31 | LOW |
| Corecap Advisors Inc | Investment Advisor/Hedge Fund | 0.1171 | 36209 | -1177 | 2022-12-31 | MED |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
Kauplemise vahendustasu
0
- 1:1
Finantsvõimendus
1:1
- 20
- 100
- 500
- 1000
- 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind
Close
Lühike Pikk
Anixa Biosciences, Inc. Company profile
Ettevõttest Anixa Biosciences, Inc.
Anixa Biosciences, Inc. on biotehnoloogiaettevõte. Ettevõte arendab ravimeid ja vaktsiine, mis keskenduvad onkoloogiale ja nakkushaigustele. Ettevõte arendab kimeerilise endokriinse retseptori T-rakkude tehnoloogiat, kimeerilise antigeeni retseptori T-rakkude (CAR-T) tehnoloogiat, mis keskendub munasarjavähi ravile, ning COVID-19 raviks mõeldud viirusevastaseid ravimikandidaate, mis keskenduvad viiruse teatavate viirusvalkude funktsioonide pärssimisele. Samuti töötab ta välja vaktsiini kolmiknegatiivse rinnavähi (TNBC), rinnavähi surmava vormi vastu, ja vaktsiini munasarjavähi vastu. Tema CAR-T-tehnoloogiat saab kasutada mitmete soliidtuumoritüüpide raviks. Ettevõtte segmentide hulka kuuluvad CAR-T terapeutikumid, vähivastased vaktsiinid, viirusevastased terapeutikumid, vähidiagnostika ja patendilitsentsid. Ettevõtte tütarettevõte Certainty Therapeutics, Inc. (Certainty) arendab vähivastaseid immuunravi ravimeid.
| Industry: | Biotechnology & Medical Research (NEC) |
3150 Almaden Expy Ste 250
SAN JOSE
CALIFORNIA 95118
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com